Respiratory Disease News

Medindia's Press Release’ section provides the latest press release on Respiratory Disease from across the world for the global audience. This page links to 843 Respiratory Disease press releases.

Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)

ST ANDREWS, Scotland , Jan. 19, 2022 /PRNewswire/ -- Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), today ...

First-Of-Its-Kind Project To Use Private-Sector Funding to Reduce Asthma for NYC Medicaid Recipients

Innovative financing model aims to improve health and reduce healthcare spending NEW YORK , Jan. 12, 2022 /PRNewswire/ -- The New York Healthy Homes Collaborative (NYHHC) today announced the launch of an innovative $4.75 million ...

Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China

The license agreement provides Nuance Pharma exclusive rights to develop and commercialize AeroFact for treatment of Respiratory Distress Syndrome (RDS) in all of Greater China. SHANGHAI , Dec. 22, 2021 /PRNewswire/ -- Aerogen Pharma, a ...

FDA APPROVES TEZSPIRE™ (TEZEPELUMAB-EKKO) IN THE U.S. FOR SEVERE ASTHMA

First and Only Biologic to Consistently and Significantly Reduce Exacerbations in a Broad Population of Severe Asthma Patients THOUSAND OAKS, Calif. , Dec. 17, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and ...

Innovative Device Shows Growing Success for Patients in Respiratory Distress

Since its Emergency Use Authorization in the United States, Intersurgical's StarMed CaStar R Hood has been providing relief and comfort to patients in respiratory distress in dozens of hospitals, teaching institutions, and hospital systems across ...

Pneumagen initiates Phase 1 trial of Neumifil, a novel, intranasal pan anti-viral therapeutic for the prophylaxis and treatment of viral Respiratory Tract Infections

- Neumifil is a novel intranasal spray with the potential to transform the prophylaxis and treatment of a range of important viral respiratory tract infections (RTIs), including influenza and COVID-19 ST ANDREWS, Scotland , Nov. 10, 2021 ...

Vietnam Leads the way with SOS Stool Method to Diagnose TB

Vietnam, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Vietnam is the first country in the world to routinely use an innovative method to diagnose tuberculosis (TB) using stool. The Simple One-Step Stool Method, developed by KNCV Tuberculosis ...

Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray

SHANGHAI , Oct. 21, 2021 /PRNewswire/ -- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (''Shandong Luoxin''), a subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd. ("Luoxin Pharmaceutical" or "the company") , signed a ...

PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research

SANDUSKY, Ohio , Oct. 15, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG's ...

Akeso is Rapidly Advancing The Phase II Clinical Trial of IL-4R Monoclonal Antibody (AK120) for the Treatment of Atopic Dermatitis and Asthma

HONG KONG , Oct. 15, 2021 /PRNewswire/ -- Akeso, Inc. (the Company, 9926.HK) announces that the Company's self-developed innovative drug candidate, IL-4R monoclonal antibody (AK120), was approved by the Center for Drug Evaluation (CDE) of ...

First
Prev
1
2
3
4
5
6
7
8
9
10
Next
Last